Stablepharma appoints Professor Saul Faust to the Advisory Board

Stablepharma are delighted to announce that Professor Saul Faust has accepted a position on Stablepharma’s Advisory Board. Professor Faust BMA, MBBS, FRCPCH, PhD, FHEA Professor or Paediatric Immunology and Infectious Diseases at the University of Southampton and Director of the NIHR Southampton Clinical Research Facility. He is currently leading the UK national 3rd dose COVID-19 […]

Read More